Masaaki Eto

933 total citations
49 papers, 713 citations indexed

About

Masaaki Eto is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cancer Research. According to data from OpenAlex, Masaaki Eto has authored 49 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Surgery and 13 papers in Cancer Research. Recurrent topics in Masaaki Eto's work include Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers), Lipoproteins and Cardiovascular Health (16 papers) and Cancer, Lipids, and Metabolism (13 papers). Masaaki Eto is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers), Lipoproteins and Cardiovascular Health (16 papers) and Cancer, Lipids, and Metabolism (13 papers). Masaaki Eto collaborates with scholars based in Japan, Greece and China. Masaaki Eto's co-authors include Yasunori Iwashima, Mieko Saito, Hiroaki Sano, Seikoh Horiuchi, Kohei Kaku, Kiyoshi Watanabe, Akira Hata, Fumitaka Ushikubi, Masafumi Matsuda and Akizuki Morikawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Masaaki Eto

47 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masaaki Eto Japan 14 284 239 167 138 84 49 713
Despina Tsorotes Australia 12 222 0.8× 110 0.5× 333 2.0× 249 1.8× 177 2.1× 12 890
Hyun Wha Chung South Korea 9 214 0.8× 128 0.5× 227 1.4× 78 0.6× 47 0.6× 13 574
Chao‐Sheng Lo Canada 18 251 0.9× 119 0.5× 424 2.5× 196 1.4× 58 0.7× 34 875
Jun Honjo Japan 12 268 0.9× 202 0.8× 240 1.4× 60 0.4× 41 0.5× 19 634
Keita Hiragushi Japan 8 117 0.4× 77 0.3× 233 1.4× 181 1.3× 61 0.7× 11 689
Shany Blum Israel 14 135 0.5× 209 0.9× 246 1.5× 121 0.9× 56 0.7× 21 1.0k
Jiaqing Shao China 16 261 0.9× 168 0.7× 250 1.5× 114 0.8× 13 0.2× 60 804
Haitao Shen China 17 112 0.4× 199 0.8× 306 1.8× 49 0.4× 30 0.4× 32 773
Hiroaki Akai Japan 16 160 0.6× 127 0.5× 328 2.0× 65 0.5× 186 2.2× 32 754
L. Selmeci Hungary 14 148 0.5× 123 0.5× 174 1.0× 122 0.9× 53 0.6× 51 705

Countries citing papers authored by Masaaki Eto

Since Specialization
Citations

This map shows the geographic impact of Masaaki Eto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaaki Eto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaaki Eto more than expected).

Fields of papers citing papers by Masaaki Eto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaaki Eto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaaki Eto. The network helps show where Masaaki Eto may publish in the future.

Co-authorship network of co-authors of Masaaki Eto

This figure shows the co-authorship network connecting the top 25 collaborators of Masaaki Eto. A scholar is included among the top collaborators of Masaaki Eto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaaki Eto. Masaaki Eto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Irie, Kei, Atsushi Nakagawa, Masaaki Eto, et al.. (2023). Population pharmacokinetics and exposure–clinical outcome relationship of remdesivir major metabolite GS‐441524 in patients with moderate and severe COVID‐19. CPT Pharmacometrics & Systems Pharmacology. 12(4). 513–521. 5 indexed citations
2.
Tsugawa, Naoko, Takayuki Sugiyama, Hiroaki Ikesue, et al.. (2022). Association between 25-hydroxyvitamin D levels and COVID-19 severity. Clinical Nutrition ESPEN. 49. 256–263. 6 indexed citations
3.
Ohtake, Nobuaki, Mieko Saito, Masaaki Eto, & Kenjiro Seki. (2014). Exendin-4 promotes the membrane trafficking of the AMPA receptor GluR1 subunit and ADAM10 in the mouse neocortex. Regulatory Peptides. 190-191. 1–11. 35 indexed citations
4.
Yokoyama, Shinji, Shizuya Yamashita, Shun Ishibashi, et al.. (2012). Background to Discuss Guidelines for Control of Plasma HDL-Cholesterol in Japan*. Journal of Atherosclerosis and Thrombosis. 19(3). 207–212. 4 indexed citations
5.
Arai, Hidenori, Shun Ishibashi, Hideaki Bujo, et al.. (2011). Management of Type IIb Dyslipidemia. Journal of Atherosclerosis and Thrombosis. 19(2). 105–114. 10 indexed citations
6.
Gotoda, Takanari, Koji Shirai, Takao Ohta, et al.. (2011). Diagnosis and Management of Type I and Type V Hyperlipoproteinemia. Journal of Atherosclerosis and Thrombosis. 19(1). 1–12. 64 indexed citations
7.
Okubo, Minoru, Mieko Saito, Tetsu Ebara, et al.. (2007). A novel complex deletion–insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency. Molecular Genetics and Metabolism. 92(3). 229–233. 31 indexed citations
8.
Saito, Mieko, et al.. (2006). Plasma lipid levels and nutritional intake in childhood- and adolescence-onset young type 1 diabetic patients in Japan. Diabetes Research and Clinical Practice. 73(1). 29–34. 6 indexed citations
9.
Saito, Mieko, Masaaki Eto, & Kohei Kaku. (2002). Remnant-like lipoprotein particles in type 2 diabetic patients with apolipoprotein E3/3 and apolipoprotein E2 genotypes. Metabolism. 51(8). 964–969. 6 indexed citations
10.
Eto, Masaaki, Mieko Saito, Fumiko Kawasaki, et al.. (2002). Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients. American Journal of Kidney Diseases. 40(2). 243–251. 75 indexed citations
11.
Matsuda, Masafumi, Fumiko Kawasaki, Yoshiki Mikami, et al.. (2002). Rescue of beta-cell exhaustion by diazoxide after the development of diabetes mellitus in rats with streptozotocin-induced diabetes. European Journal of Pharmacology. 453(1). 141–148. 19 indexed citations
12.
Eto, Masaaki, et al.. (2002). [Studies on the mechanism of elevation of serum PIVKA-II levels in alcoholic liver cirrhosis].. PubMed. 50(3). 289–95. 6 indexed citations
13.
Iwashima, Yasunori, Masaaki Eto, Akira Hata, et al.. (2000). Advanced Glycation End Products-Induced Gene Expression of Scavenger Receptors in Cultured Human Monocyte-Derived Macrophages. Biochemical and Biophysical Research Communications. 277(2). 368–380. 91 indexed citations
14.
Abiko, Atsuko, Masaaki Eto, Isao Makino, Norie Araki, & Seikoh Horiuchi. (2000). Increased levels of advanced glycosylation end products in the kidney and liver from spontaneously diabetic Chinese hamsters determined by immunochemical assay. Metabolism. 49(5). 567–573. 2 indexed citations
15.
Iwashima, Yasunori, Masaaki Eto, Seikoh Horiuchi, & Hiroaki Sano. (1999). Advanced Glycation End Product-Induced Peroxisome Proliferator-Activated Receptor γ Gene Expression in the Cultured Mesangial Cells. Biochemical and Biophysical Research Communications. 264(2). 441–448. 51 indexed citations
16.
Itoh, Hiroshi, Masashi Yoneda, Yoshihiro Miyamoto, et al.. (1995). Rapid gastric emptying and pathological changes of vagus nerve in the spontaneously diabetic Chinese hamster. Diabetes Research and Clinical Practice. 28(2). 89–95. 9 indexed citations
17.
Sekiguchi, M, Kiyoshi Watanabe, Masaaki Eto, et al.. (1991). Polyol pathway in tissues of spontaneously diabetic Chinese hamsters (Cricetulus griseus) and the effect of an aldose reductase inhibitor, ONO-2235. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 98(4). 637–640. 4 indexed citations
18.
Eto, Masaaki, et al.. (1989). Apolipoprotein-E2 and Hyperlipoproteinemia in Noninsulin-Dependent Diabetes Mellitus*. The Journal of Clinical Endocrinology & Metabolism. 69(6). 1207–1212. 15 indexed citations
19.
Eto, Masaaki, Kiyoshi Watanabe, Eiji Oshima, et al.. (1987). Apolipoprotein E Allele Frequencies in the General Japanese Population. The Journal of Japan Atherosclerosis Society. 15(1). 191–194. 1 indexed citations
20.
Eto, Masaaki, Kiyoshi Watanabe, M Sekiguchi, et al.. (1987). Metabolic and morphological changes of the heart in Chinese hamsters (CHAD strain) with spontaneous long-term diabetes. Diabetes Research and Clinical Practice. 3(6). 297–305. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Despina Tsorotes Breakdown of academic impact, for papers by Hyun Wha Chung Breakdown of academic impact, for papers by Chao‐Sheng Lo Breakdown of academic impact, for papers by Jun Honjo Breakdown of academic impact, for papers by Keita Hiragushi Breakdown of academic impact, for papers by Shany Blum Breakdown of academic impact, for papers by Jiaqing Shao Breakdown of academic impact, for papers by Haitao Shen Breakdown of academic impact, for papers by Hiroaki Akai Breakdown of academic impact, for papers by L. Selmeci
Rankless by CCL
2026